VIDEO: New drug classes for multiple myeloma treatment

Editor's note: This is an automatically generated transcript. Please notify editor@healio.com if there are concerns regarding accuracy of the transcription.

If you look at the last 20 years as a marker for latest, there's been substantial development. So, we now have multiple new classes of drugs, multiple agents that are FDA-approved for the treatment of multiple myeloma, more than 15, 16 different drugs that have become available in that period. If you focus more recent times in the last five or so years, I think most of the excitement has been with immunotherapies, particularly CAR T cells and bispecific antibodies, which now, again, there are two FDA-approved CAR T cells and three different bispecific antibodies that are approved. So, that I would say is probably the most significant advance in the last five years.